Subsequently, Blee and colleagues showed that, in the context of Pten/Tp53 alterations, ERG is important for maintaining the luminal epithelial lineage in prostate cancer cells by repressing the expression of cell cycle genes and upregulating AR pathway genes (52). The gene discussed is ERG; the disease is prostate cancer.